Kyoto University

A chatbot willing to take on questions of all kinds – from the serious to the comical – is the latest representation of Jesus for the AI age

Retrieved on: 
Tuesday, August 1, 2023
Christianity, Artificial intelligence, ChatGPT, Human, Catholic Church, Prothero, Bible, Death, Life, Buddhism, Spirituality, Kyoto University, Entertainment, Baking, Tourism, Jewellery, Customer service, Medical device, Facebook, AI

Jesus has been portrayed in many different ways: from a prophet who alerts his audience to the world’s imminent end to a philosopher who reflects on the nature of life.

Key Points: 
  • Jesus has been portrayed in many different ways: from a prophet who alerts his audience to the world’s imminent end to a philosopher who reflects on the nature of life.
  • But no one has called Jesus an internet guru – that is, until now.

Reinterpreting Jesus

    • Prothero argues that a primarily peaceful Jesus was perceived to conflict with these gender norms, and so Jesus’ physical prowess was emphasized.
    • Sugirtharajah, around the same time in India, Jesus was represented as a Hindu mystic or guru by Indian theologians like Ponnambalam Ramanathan in order to make Jesus more relatable for Indian Christians and to show how his spiritual teachings could be usefully adopted by faithful Hindus.
    • The AI Jesus who engages individuals online in the form of a chatbot is the latest in this ongoing pattern of reinterpretation, geared to making Jesus suited to the current times.
    • On AI Jesus’ Twitch channel, users consistently treat this chatbot Jesus as an authority in both personal and spiritual matters.

AI Jesus at work

    • AI Jesus represents one of the newest examples in the growing field of AI spirituality.
    • AI Jesus functions very similarly to this kind of artificial intelligence system and answers religious questions, among others.
    • This AI Jesus also adjusts his responses as the chatbot learns from user input over time.

AI spirituality beyond AI Jesus

    • This chatbot guru is facing increasing competition from other sources of AI spirituality.
    • Like AI Jesus, he is represented as a human being who freely shares his spiritual wisdom and can be messaged on Facebook anytime, anywhere – provided one has an internet connection.
    • In any case, the millennia-old trend of refashioning spiritual leaders to meet contemporary needs is likely to continue well after AI Jesus has become a religious presence of the distant past.

2023 Tsinghua Amgen Scholars Program Kicks Off

Retrieved on: 
Thursday, July 27, 2023
ASP, Scholar, University, U.S. Army World Class Athlete Program, Pharmacy, National university, Biotechnology, COVID-19, UCPH School of Pharmaceutical Sciences, University of Tokyo, National University of Singapore, Research, Science, Student, School, Kyoto University, Tsinghua University, Knowledge, Dean (education), Management, Amgen

SHANGHAI, July 27, 2023 /PRNewswire/ -- Recently, 2023 Amgen Scholar Program (ASP) was opened in China, partnering with Tsinghua University, one of China's top academic institutions and influential universities. 24 undergraduates were selected as Amgen Scholars from across the globe to participate in this program with one-third of the chosen scholars coming from international universities this year. They will have the opportunity to engage in cutting-edge scientific research with world class scientists in state-of-the-art research laboratories. It is the largest in-person summer camp ASP held since the COVID-19 global pandemic.

Key Points: 
  • SHANGHAI, July 27, 2023 /PRNewswire/ -- Recently, 2023 Amgen Scholar Program (ASP) was opened in China, partnering with Tsinghua University, one of China's top academic institutions and influential universities.
  • 24 undergraduates were selected as Amgen Scholars from across the globe to participate in this program with one-third of the chosen scholars coming from international universities this year.
  • Amgen Scholars at the Tsinghua University consists of eight weeks of intensive research program in a wide range of fields in biomedical sciences.
  • says Ligong Chen, Associate Dean, School of Pharmaceutical Sciences, Tsinghua University Program Director, Tsinghua Amgen Scholars Program.

SK-II UNVEILS SKIN AGING DISCOVERIES AT THE WORLD CONGRESS OF DERMATOLOGY 2023 AND INAUGURATES THE PITERA™ SCIENCE EXPERT PANEL

Retrieved on: 
Wednesday, July 19, 2023
Trigger, Cream, SK-II, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Beth Israel Deaconess Medical Center, AT-02, Weill Cornell Graduate School of Medical Sciences, Medicine, DEPT, Physician, Postgraduate education, Ageing, Kyushu University, Research, Associate, Science, Harvard Medical School, Congress, Professor, Kyoto University, MPH, Human, Skin, Cosmetics, Pharmaceutical industry, Management, Dermatology, MD

SINGAPORE, July 19, 2023 /PRNewswire/ -- Pushing the boundaries of skin aging science and innovations, global prestige skincare brand SK-II debuts new skin aging discoveries and innovations and inaugurates its first PITERA™ Science Expert Panel with some of the world's leading dermatologists. 

Key Points: 
  • SINGAPORE, July 19, 2023 /PRNewswire/ -- Pushing the boundaries of skin aging science and innovations, global prestige skincare brand SK-II debuts new skin aging discoveries and innovations and inaugurates its first PITERA™ Science Expert Panel with some of the world's leading dermatologists.
  • A pioneering longitudinal 10-year Akita Study and the PITERA™ 24/7 Skin Fluctuation Study on young skin has contributed to PITERA™ breakthroughs on skin.
  • If left untreated, the aging chain reaction can lead to accelerated aging signs, resulting in more severe signs of premature aging.
  • Following the World Congress of Dermatology, SK-II inaugurates its first-ever PITERA™ Science Expert Panel in recognition of some of the world's foremost dermatologists who have partnered with SK-II to advance skin aging science.

CGD CTO Florin Udrea Inducted Into Prestigious ISPSD Hall of Fame

Retrieved on: 
Friday, June 16, 2023
Semiconductor, Environment, Technology, Sustainability, Alternative Energy, Green Technology, Energy, University, ISPSD, Use, Gallium nitride, Electronics, University of Cambridge, Research, Sensor, Carbon, Florin, IEEE, Silicon carbide, WBG, Gate, International Symposium on Power Semiconductor Devices and ICs, Udrea, Sensing, Hall, Diamond, Kyoto University, CGD, Silicon, Royal Academy of Arts, Consumer electronics, Management, Engineering

Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener electronics possible, is delighted to announce that co-founder and CTO, Professor Florin Udrea was recently inducted into the IEEE ISPSD (International Symposium on Power Semiconductor Devices) Hall of Fame, which honours individuals who have made high impact contributions in advancing power semiconductor technology and/or sustaining the success of ISPSD.

Key Points: 
  • Cambridge GaN Devices (CGD) , the fabless, clean-tech semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener electronics possible, is delighted to announce that co-founder and CTO, Professor Florin Udrea was recently inducted into the IEEE ISPSD (International Symposium on Power Semiconductor Devices) Hall of Fame, which honours individuals who have made high impact contributions in advancing power semiconductor technology and/or sustaining the success of ISPSD.
  • FLORIN UDREA | CHIEF TECHNICAL OFFICER, CGD
    “It is a very great honour to be welcomed into the ISPSD Hall of Fame, and I am proud to join such an august and select group of illustrious and pioneering colleagues.
  • It is my privilege and also good fortune to be active at a time when the subject of ‘power’ has never been more relevant.
  • By working with new WBG materials such as GaN, we can all improve efficiency and reduce our carbon footprint.”
    GIORGIA LONGOBARDI | CHIEF EXECUTIVE OFFICER, CGD
    “We congratulate Florin on this well-deserved honour.

Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models

Retrieved on: 
Monday, May 29, 2023
Osaka University, Kyoto, Patient, Keio University, Kyoto University, ISID, Immunoglobulin G, Vaccine, Regulatory T cell, Pemphigus

OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.

Key Points: 
  • OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.
  • Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus.
  • Collaborators also reported that S/F-iTregs generated from samples obtained from patients with Pemphigus also showed potent inhibition of autologous T cell proliferation in vitro.
  • Tregs play a central role in managing immune self-tolerance and depleted or dysfunctional Tregs are characteristic of many autoimmune disorders.

Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models

Retrieved on: 
Monday, May 29, 2023
Osaka University, Kyoto, Patient, Keio University, Kyoto University, ISID, Immunoglobulin G, Vaccine, Regulatory T cell, Pemphigus

OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.

Key Points: 
  • OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.
  • Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus.
  • Collaborators also reported that S/F-iTregs generated from samples obtained from patients with Pemphigus also showed potent inhibition of autologous T cell proliferation in vitro.
  • Tregs play a central role in managing immune self-tolerance and depleted or dysfunctional Tregs are characteristic of many autoimmune disorders.

East West Bank Appoints Dr. Jason Hsu of Rayliant Global Advisors as Chief Economist

Retrieved on: 
Tuesday, May 23, 2023
Banking, Asset Management, Professional Services, Finance, Uncertainty, Partnership, University, Anderson School, Multimedia, UCLA Anderson School of Management, Kyoto University, Tsinghua University, National Chengchi University, University of California, Los Angeles, Bank, UCLA, Robert D. Arnott, National Advisory Committee on Institutional Quality and Integrity, Data science, Cryptocurrency

East West Bancorp, Inc. ("East West" or the "Company") (Nasdaq: EWBC), parent company of East West Bank , today announced the appointment of Dr. Jason Hsu , founder and Chief Investment Officer of Rayliant Global Advisors (“Rayliant”), as the Chief Economist for East West Bank.

Key Points: 
  • East West Bancorp, Inc. ("East West" or the "Company") (Nasdaq: EWBC), parent company of East West Bank , today announced the appointment of Dr. Jason Hsu , founder and Chief Investment Officer of Rayliant Global Advisors (“Rayliant”), as the Chief Economist for East West Bank.
  • View the full release here: https://www.businesswire.com/news/home/20230523006078/en/
    Rayliant founder and new East West Bank Chief Economist Dr. Jason Hsu (Photo: Business Wire)
    “Dr.
  • Hsu is a preeminent leader in the fields of finance and investment management, and we are delighted to welcome him as the Chief Economist of East West Bank,” stated Dominic Ng, Chairman and Chief Executive Officer of East West Bancorp.
  • “East West Bank and Rayliant were both founded on a shared mission of serving as the bridge between the East and West.

Mitsubishi Corporation Invests in Kyoto Fusioneering, a spin-off from Kyoto University

Retrieved on: 
Wednesday, May 17, 2023
Carbon, Deuterium, University, MC, Electricity, KF, Light, Research, Government, Tritium, Seawater, Kyoto University, Helium, CO2, Lithium, Renewable energy

Its establishment in 2019 was based on decades of fusion research and development by Kyoto University.

Key Points: 
  • Its establishment in 2019 was based on decades of fusion research and development by Kyoto University.
  • KF specializes in key components and integrated systems that are required in order to build fusion reactors and fusion power plants.
  • KF's strategic aim is to build a fusion energy supply chain by leveraging Japan's leading manufacturing capabilities.
  • (Based on the provisional translation of "Fusion Energy Innovation Strategy" adopted by Japan's Integrated Innovation Strategy Promotion Council on April 14, 2023)

Fujitsu, Kyoto University, and Chordia Therapeutics launch AI trials to discover biomarkers for new cancer drugs

Retrieved on: 
Wednesday, May 17, 2023
Probability, Drug development, Cancer, Biomarker, RNA, Patient, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto University, Fujitsu, Diagnosis, Therapy, Gene, Genome, Pharmaceutical industry, Chordia

This information will assist researchers working to discover biomarkers for patient stratification that can be used to determine the efficacy of cancer treatments that target RNA regulatory stress (5), under development by Kyoto University and Chordia since May 2018.

Key Points: 
  • This information will assist researchers working to discover biomarkers for patient stratification that can be used to determine the efficacy of cancer treatments that target RNA regulatory stress (5), under development by Kyoto University and Chordia since May 2018.
  • Through this demonstration, Fujitsu, Kyoto University, and Chordia Therapeutics aim to realize new cancer treatments personalized to individual patients' genetic characteristics, cancer symptoms and progression, ultimately improving patient outcomes and well-being.
  • A variety of biomarkers are currently used in the medical field for preventative care, diagnosis, and treatment selection of cancer.
  • In clinical trials, biomarkers make it possible for drug development researchers to focus on specific characteristics, improving the likelihood of developing successful and effective new drug candidates.

ISARA Expands Strategic Leadership, Appoints CEO and Executive Chairman

Retrieved on: 
Wednesday, May 10, 2023
United States National Security Council, United Nations Security Council, PQC, White House, Telecom, University, Doctor of Philosophy, Open Kernel Labs, Policy, Emerging, Research, Kevin Mital, Special Assistance Program (Australian education), Dartmouth College, Government, White, Critical infrastructure, Organization, Microsoft, Engineering, Kyoto University, Gen Digital, Physics, National security council, AI, Mathematics, Quantum computing, Management, Cryptocurrency

WATERLOO, ON, May 10, 2023 /PRNewswire/ -- ISARA, the leader in post-quantum cryptography (PQC) and cryptographic risk management, today announced two executive leadership appointments that will expand and support the company's strategic direction. Atsushi Yamada was named CEO and Amit Mital was named executive chairman. Both bring significant cryptographic and technological leadership experience in enterprise and government, as ISARA expands its focus to include post-quantum cryptography professional services.

Key Points: 
  • Atsushi Yamada was named CEO and Amit Mital was named executive chairman.
  • Both bring significant cryptographic and technological leadership experience in enterprise and government, as ISARA expands its focus to include post-quantum cryptography professional services.
  • "At ISARA, we pride ourselves on building a quantum-safe world," stated Atsushi Yamada, CEO of ISARA.
  • "ISARA has an excellent crypto-agile technology foundation and I look forward to taking the company to a new level and helping organizations manage their quantum-safe journeys every step of the way," said Amit Mital, executive chairman of ISARA.